
NeoGenomics, Inc.: updates and filings
Price
$14.82
November 20, 2026Market cap $1.9B
What Ploutos Investor adds for NeoGenomics
Part of Ploutos Investor, €9.99 a month
- The full history: 14 fiscal years, from 2012
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 28, 2026next Jan 28, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
July 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 28, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 28, 2026Results of operationsForm8-K
- Oct 5, 2026Results of operations, officer or director change, amended articles or bylawsForm8-K
- Aug 25, 2026Shares registered for employeesFormS-8
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 11, 2026Officer or director changeForm8-K
- Jul 30, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 28, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 28, 2026Results of operationsForm8-K
- Jul 22, 2026Regulation FD disclosure, other material events (amendment)Form8-K/A
- Jul 20, 2026Regulation FD disclosure, other material eventsForm8-K
- Jun 25, 2026Officer or director change, Regulation FD disclosureForm8-K
- Jun 22, 2026Material agreement entered, new material financial obligation, unregistered sale of shares, other material eventsForm8-K
- Jun 17, 2026Other material eventsForm8-K
- Jun 15, 2026Other material eventsForm8-K
- May 22, 2026Officer or director change, shareholder voteForm8-K
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 7, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 28, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 28, 2026Results of operationsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 28, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 28, 2026 | 8-K | Results of operations | Document |
| Oct 5, 2026 | 8-K | Results of operations, officer or director change, amended articles or bylaws | Document |
| Aug 25, 2026 | S-8 | Shares registered for employees | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 11, 2026 | 8-K | Officer or director change | Document |
| Jul 30, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 28, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 28, 2026 | 8-K | Results of operations | Document |
| Jul 22, 2026 | 8-K/A | Regulation FD disclosure, other material events (amendment) | Document |
| Jul 20, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Jun 25, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Jun 22, 2026 | 8-K | Material agreement entered, new material financial obligation, unregistered sale of shares, other material events | Document |
| Jun 17, 2026 | 8-K | Other material events | Document |
| Jun 15, 2026 | 8-K | Other material events | Document |
| May 22, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 7, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 28, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 28, 2026 | 8-K | Results of operations | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 10, 1999.
The full analysis
What do NeoGenomics's filings show?
The filings are where every one of NeoGenomics's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.